Literature DB >> 30155951

Lisinopril-associated bullous pemphigoid in an elderly woman: a case report of a rare adverse drug reaction.

Rami A Ballout1, Umayya Musharrafieh2, Joe Khattar2.   

Abstract

An 87-year-old woman with a long-standing history of hypertension, hypothyroidism and diabetes presented to us with scaly and pruritic vesicles of an erythematous base and crusted surface of 2-month duration. They first appeared on her abdomen and gradually spread to her lower back, thighs, before spreading to her upper and lower limbs. Her lesions were non-painful, aggravated by sun exposure only, and sparing mucous membranes. Nikolsky sign was positive with no discernible fluid-filled bullae. History was remarkable only for a doubling of her Lisinopril dosage 2 months prior to the appearance of her lesions, with no other potential environmental and/or drug triggers recognizable on history taking. In light of the appearance of her lesions after her Lisinopril dose escalation, in the absence of any other discernible triggers, an adverse drug reaction (ADR) was entertained, yielding a corresponding Naranjo ADR probability score of 7. Particularly, drug-induced pemphigus foliaceus was initially suspected given her clinical presentation and the morphology and distribution of her lesions. However, her skin biopsy altered our diagnosis to drug-induced bullous pemphigoid (BP) instead, making this the second case reported to date on Lisinopril-induced BP, and the first to report a dose-response variant of this adverse reaction.
© 2018 The British Pharmacological Society.

Entities:  

Keywords:  angiotensin II receptor; angiotensin-converting enzyme (ACE); autoimmune; blisters; drug-induced; pharmacovigilance

Mesh:

Substances:

Year:  2018        PMID: 30155951      PMCID: PMC6177705          DOI: 10.1111/bcp.13737

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  21 in total

1.  Can pemphigoid be provoked by lisinopril?

Authors:  A Kalińska-Bienias; T T Rogoziński; K Woźniak; C Kowalewski
Journal:  Br J Dermatol       Date:  2006-10       Impact factor: 9.302

Review 2.  "Two-step" pemphigus induction by ACE-inhibitors.

Authors:  V Ruocco; R A Satriano; V Guerrera
Journal:  Int J Dermatol       Date:  1992-01       Impact factor: 2.736

Review 3.  Diagnosis and clinical features of pemphigus foliaceus.

Authors:  Kirk A James; Donna A Culton; Luis A Diaz
Journal:  Dermatol Clin       Date:  2011-07       Impact factor: 3.478

4.  Drug-induced pemphigus.

Authors:  Sarah Brenner; Ilan Goldberg
Journal:  Clin Dermatol       Date:  2011 Jul-Aug       Impact factor: 3.541

Review 5.  Angiotensin converting enzyme (ACE) inhibitors and kinin metabolism: evidence that ACE inhibitors may inhibit a kininase other than ACE.

Authors:  D J Campbell
Journal:  Clin Exp Pharmacol Physiol       Date:  1995-12       Impact factor: 2.557

6.  Antigen identification in drug-induced bullous pemphigoid.

Authors:  E P Smith; T B Taylor; L J Meyer; J J Zone
Journal:  J Am Acad Dermatol       Date:  1993-11       Impact factor: 11.527

7.  Pemphigus foliaceus: an adverse reaction to lisinopril.

Authors:  C R S Patterson; M G Davies
Journal:  J Dermatolog Treat       Date:  2004-01       Impact factor: 3.359

8.  Medication history of a series of patients with bullous pemphigoid from northern Greece - observations and discussion.

Authors:  Aikaterini Patsatsi; Timoleon-Achilleas Vyzantiadis; Fotis Chrysomallis; Despina Devliotou-Panagiotidou; Dimitrios Sotiriadis
Journal:  Int J Dermatol       Date:  2009-02       Impact factor: 2.736

9.  The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY.

Authors:  Simon D Harding; Joanna L Sharman; Elena Faccenda; Chris Southan; Adam J Pawson; Sam Ireland; Alasdair J G Gray; Liam Bruce; Stephen P H Alexander; Stephen Anderton; Clare Bryant; Anthony P Davenport; Christian Doerig; Doriano Fabbro; Francesca Levi-Schaffer; Michael Spedding; Jamie A Davies
Journal:  Nucleic Acids Res       Date:  2018-01-04       Impact factor: 16.971

10.  Pemphigus foliaceus as a differential diagnosis in vesicobullous lesions.

Authors:  Louise de Almeida Ferreira Fonseca; Célia Antônia Xavier de Moraes Alves; Ivan Aprahamian; Clóvis Antônio Lopes Pinto
Journal:  Einstein (Sao Paulo)       Date:  2017 Apr-Jun
View more
  1 in total

1.  Lisinopril-associated bullous pemphigoid in an elderly woman: a case report of a rare adverse drug reaction.

Authors:  Rami A Ballout; Umayya Musharrafieh; Joe Khattar
Journal:  Br J Clin Pharmacol       Date:  2018-08-29       Impact factor: 4.335

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.